Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.
About
Viridian Therapeutics is a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for patients with serious and rare diseases. Their expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for validated drug targets and disease-driving mechanisms in autoimmune and rare diseases. The company is advancing multiple late-stage candidates for thyroid eye disease (TED) and a portfolio of neonatal Fc receptor (FcRn) inhibitors for autoimmune diseases.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Viridian Therapeutics, Inc. do?
Viridian Therapeutics is a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for patients with serious and rare diseases. Their expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for validated drug targets and disease-driving mechanisms in autoimmune and rare diseases. The company is advancing multiple late-stage candidates for thyroid eye disease (TED) and a po…
How much funding has Viridian Therapeutics, Inc. raised?
Viridian Therapeutics, Inc. has raised a total of $15M in funding. The most recent round on record is Series A.
Where is Viridian Therapeutics, Inc. headquartered?
Viridian Therapeutics, Inc. is headquartered in Waltham, United States.
When was Viridian Therapeutics, Inc. founded?
Viridian Therapeutics, Inc. was founded in 2017.
What industry does Viridian Therapeutics, Inc. operate in?
Viridian Therapeutics, Inc. operates in Biotechnology, Pharmaceuticals, Healthcare, Life Sciences, Drug Discovery, Clinical Trials.
What is Viridian Therapeutics, Inc.'s current status?
Viridian Therapeutics, Inc.'s current operating status is: Acquired.
Similar Startups